Announced
Completed
Financials
Tags
Pharmaceuticals
specialty pharmaceuticals
France
Single Bidder
Acquisition
Friendly
Majority
Private
Cross Border
Private Equity
Completed
Synopsis
Stanley Capital Partners, a private equity firm, completed the acquisition of a majority stake in Laboratoire XO, a French pharmaceutical group. Financial terms were not disclosed. "SCP is pleased to partner with Karine Pinon and her impressive management team to accelerate Lab XO’s growth with a global footprint. All parties share a vision to couple further acquisitive growth with building leading lifecycle management capabilities to create a formidable specialist pharma player providing essential medicines to its customers in the patient community," Simon Cottle, SCP Founding Partner.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.